Boundless Bio, Inc.

BOLD · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$26,587$23,706$10,951$34,289
Short-Term Investments$125,527$97,046$55,766$38,744
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$2,276$3,452$1,320$1,537
Total Curr. Assets$154,390$124,204$68,037$74,570
Property Plant & Equip (Net)$51,360$4,575$7,726$3,095
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$560$0$34,988
Tax Assets$0$0$0$0
Other NC Assets$659$555$1,066$1,066
Total NC Assets$52,019$5,690$8,792$39,149
Other Assets$0$0$0$0
Total Assets$206,409$129,894$76,829$113,719
Liabilities
Payables$1,274$2,222$1,402$1,075
Short-Term Debt$0$2,195$2,338$377
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$6,861$4,942$3,988$2,415
Total Curr. Liab.$8,135$9,359$7,728$3,867
LT Debt$47,632$0$2,845$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$247,617$147,952$148,041
Total NC Liab.$47,632$247,617$150,797$148,041
Other Liabilities$0$0$0$0
Cap. Leases$47,632$2,195$5,183$377
Total Liabilities$55,767$256,976$158,525$151,908
Equity
Pref Stock$0$0$0$0
Common Stock$2$0$0$2
Retained Earnings-$201,472-$136,109-$86,675-$40,774
AOCI$121$40-$398-$175
Other Equity$351,991$8,987$5,377$2,758
Total Equity$150,642-$127,082-$81,696-$38,189
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$206,409$129,894$76,829$113,719
Net Debt$21,045-$21,511-$5,768-$33,912